BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 19383978)

  • 1. New insights into mTOR signaling: mTORC2 and beyond.
    Alessi DR; Pearce LR; García-Martínez JM
    Sci Signal; 2009 Apr; 2(67):pe27. PubMed ID: 19383978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1).
    García-Martínez JM; Alessi DR
    Biochem J; 2008 Dec; 416(3):375-85. PubMed ID: 18925875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling.
    Julien LA; Carriere A; Moreau J; Roux PP
    Mol Cell Biol; 2010 Feb; 30(4):908-21. PubMed ID: 19995915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mTOR and Akt signaling in cancer: SGK cycles in.
    Toker A
    Mol Cell; 2008 Jul; 31(1):6-8. PubMed ID: 18614042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TORC-specific phosphorylation of mammalian target of rapamycin (mTOR): phospho-Ser2481 is a marker for intact mTOR signaling complex 2.
    Copp J; Manning G; Hunter T
    Cancer Res; 2009 Mar; 69(5):1821-7. PubMed ID: 19244117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-induced endothelial proliferation requires both mTORC1 and mTORC2.
    Li W; Petrimpol M; Molle KD; Hall MN; Battegay EJ; Humar R
    Circ Res; 2007 Jan; 100(1):79-87. PubMed ID: 17110594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRR5, a novel component of mTOR complex 2, regulates platelet-derived growth factor receptor beta expression and signaling.
    Woo SY; Kim DH; Jun CB; Kim YM; Haar EV; Lee SI; Hegg JW; Bandhakavi S; Griffin TJ; Kim DH
    J Biol Chem; 2007 Aug; 282(35):25604-12. PubMed ID: 17599906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoregulation of the mechanistic target of rapamycin (mTOR) complex 2 integrity is controlled by an ATP-dependent mechanism.
    Chen CH; Kiyan V; Zhylkibayev AA; Kazyken D; Bulgakova O; Page KE; Bersimbaev RI; Spooner E; Sarbassov DD
    J Biol Chem; 2013 Sep; 288(38):27019-27030. PubMed ID: 23928304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility.
    Gulati N; Karsy M; Albert L; Murali R; Jhanwar-Uniyal M
    Int J Oncol; 2009 Oct; 35(4):731-40. PubMed ID: 19724909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling events downstream of mammalian target of rapamycin complex 2 are attenuated in cells and tumors deficient for the tuberous sclerosis complex tumor suppressors.
    Huang J; Wu S; Wu CL; Manning BD
    Cancer Res; 2009 Aug; 69(15):6107-14. PubMed ID: 19602587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a).
    Brunet A; Park J; Tran H; Hu LS; Hemmings BA; Greenberg ME
    Mol Cell Biol; 2001 Feb; 21(3):952-65. PubMed ID: 11154281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ASCT2 silencing regulates mammalian target-of-rapamycin growth and survival signaling in human hepatoma cells.
    Fuchs BC; Finger RE; Onan MC; Bode BP
    Am J Physiol Cell Physiol; 2007 Jul; 293(1):C55-63. PubMed ID: 17329400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mTOR Ser-2481 autophosphorylation monitors mTORC-specific catalytic activity and clarifies rapamycin mechanism of action.
    Soliman GA; Acosta-Jaquez HA; Dunlop EA; Ekim B; Maj NE; Tee AR; Fingar DC
    J Biol Chem; 2010 Mar; 285(11):7866-79. PubMed ID: 20022946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mTOR complex 2 targets Akt for proteasomal degradation via phosphorylation at the hydrophobic motif.
    Wu YT; Ouyang W; Lazorchak AS; Liu D; Shen HM; Su B
    J Biol Chem; 2011 Apr; 286(16):14190-8. PubMed ID: 21321111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR).
    García-Martínez JM; Moran J; Clarke RG; Gray A; Cosulich SC; Chresta CM; Alessi DR
    Biochem J; 2009 Jun; 421(1):29-42. PubMed ID: 19402821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mTORC2 is the hydrophobic motif kinase for SGK1.
    Yan L; Mieulet V; Lamb RF
    Biochem J; 2008 Dec; 416(3):e19-21. PubMed ID: 19025518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mTORC2-SGK-1 acts in two environmentally responsive pathways with opposing effects on longevity.
    Mizunuma M; Neumann-Haefelin E; Moroz N; Li Y; Blackwell TK
    Aging Cell; 2014 Oct; 13(5):869-78. PubMed ID: 25040785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanical regulation of glycogen synthase kinase 3β (GSK3β) in mesenchymal stem cells is dependent on Akt protein serine 473 phosphorylation via mTORC2 protein.
    Case N; Thomas J; Sen B; Styner M; Xie Z; Galior K; Rubin J
    J Biol Chem; 2011 Nov; 286(45):39450-6. PubMed ID: 21956113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mTOR (mammalian target of rapamycin) kinase maintains integrity of mTOR complex 2.
    Chen CH; Sarbassov dos D
    J Biol Chem; 2011 Nov; 286(46):40386-94. PubMed ID: 21965657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple site acetylation of Rictor stimulates mammalian target of rapamycin complex 2 (mTORC2)-dependent phosphorylation of Akt protein.
    Glidden EJ; Gray LG; Vemuru S; Li D; Harris TE; Mayo MW
    J Biol Chem; 2012 Jan; 287(1):581-588. PubMed ID: 22084251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.